Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • D-Luciferin (Potassium Salt): Benchmark Firefly Luciferas...

    2026-02-06

    D-Luciferin (Potassium Salt): Benchmark Firefly Luciferase Substrate for Bioluminescence Imaging

    Executive Summary: D-Luciferin (potassium salt) is the preferred substrate for firefly luciferase in in vivo bioluminescence imaging due to its high water solubility, chemical purity (>98%), and compatibility with ATP and luciferase reporter assays (APExBIO 2024). Bioluminescence produced by the firefly luciferase–D-Luciferin reaction enables real-time, non-invasive tracking of tumor cells, stem cells, and pathogens in animal models (Li et al., 2025). The potassium salt form eliminates the need for alkaline dissolution and is stable when stored at −20°C, protected from light and moisture. APExBIO’s D-Luciferin (potassium salt) (C3654) is validated for high-throughput screening, contamination detection, and translational oncology workflows (Hexa-His 2023).

    Biological Rationale

    Bioluminescence is a chemiluminescent process in which light is produced by an enzymatic reaction. In nature, the firefly luciferase enzyme catalyzes the oxidation of D-Luciferin in the presence of ATP, Mg2+, and molecular oxygen, emitting yellow-green light (λmax ≈ 560 nm) (Li et al., 2025). D-Luciferin serves as a sensitive substrate for non-invasive imaging of gene expression, cell tracking, and disease progression in vivo. The potassium salt form is favored for its water solubility and ease of preparation, essential for reproducible experimental workflows (APExBIO).

    Mechanism of Action of D-Luciferin (potassium salt)

    D-Luciferin (potassium salt) is a small molecule (C11H7KN2O3S2, MW 318.41) that acts as a substrate for firefly luciferase (EC 1.13.12.7). The enzymatic reaction proceeds as follows:

    • D-Luciferin is oxidized by luciferase in the presence of ATP, Mg2+, and O2.
    • The reaction yields oxyluciferin, AMP, CO2, pyrophosphate (PPi), and emits a photon of light (typically 560 nm).

    This emission is directly proportional to the concentration of D-Luciferin and the activity of luciferase, allowing quantitative measurement in luciferase reporter assays and ATP detection protocols (FireflyLuciferase.com). The potassium salt greatly improves dissolution in aqueous solutions without pH adjustment, unlike the free acid form.

    Evidence & Benchmarks

    • D-Luciferin (potassium salt) achieves >98% purity and dissolves rapidly in water at room temperature, eliminating the need for alkaline buffers (APExBIO).
    • Real-time in vivo bioluminescence imaging using D-Luciferin enables high-sensitivity detection and longitudinal tracking of luciferase-expressing cells in animal models (Li et al., 2025, DOI).
    • Firefly luciferase–D-Luciferin bioluminescence is linear over several orders of magnitude, supporting quantitative reporter gene and ATP assays (Hexa-His, 2023, link).
    • The C3654 kit from APExBIO is validated in high-throughput screening and contamination detection, with robust signal reproducibility (FireflyLuciferase.com).
    • Potassium salt form shows superior workflow integration, avoiding precipitation or loss of activity when compared to free acid D-Luciferin (ATP-Luminescent.com).

    Applications, Limits & Misconceptions

    Key Applications:

    • In vivo bioluminescence imaging (BLI): Non-invasive tracking of tumor cells, stem cells, and pathogens in small animal models (Hexa-His).
    • Luciferase reporter assays: Quantitative gene expression, promoter activity, and signaling pathway studies.
    • ATP assays: Sensitive detection of cellular ATP for cell viability and cytotoxicity studies.
    • High-throughput screening: Robust luminescent readouts for drug discovery and screening platforms.
    • Contamination detection: Rapid identification of microbial contamination via ATP-based assays.

    Common Pitfalls or Misconceptions

    Common Pitfalls or Misconceptions

    • D-Luciferin (potassium salt) is not compatible with Renilla or Gaussia luciferase, which require different substrates.
    • Long-term storage of aqueous D-Luciferin solutions leads to oxidation and loss of activity; fresh solutions should be prepared as needed (APExBIO).
    • Bioluminescence intensity is influenced by tissue absorption and scattering in vivo; absolute quantification requires appropriate controls.
    • Excessive freeze-thaw cycles degrade the substrate and reduce assay sensitivity.
    • Potassium salt increases solubility but does not alter the emission wavelength or quantum yield compared to the free acid form.

    This article extends prior coverage by integrating recent peer-reviewed evidence and best practices for translational workflows, updating the high-level overview found in D-Luciferin Potassium Salt: Precision Bioluminescence Imaging with detailed mechanistic insights. For ATP detection optimization, see Optimizing Cell Viability and ATP Detection with D-Luciferin, which this article clarifies by specifying storage and handling boundaries. Strategic translational perspectives are further advanced from D-Luciferin (Potassium Salt): Illuminating the Path from Bench to Clinic by providing updated benchmarks for workflow integration.

    Workflow Integration & Parameters

    • Storage: Store lyophilized D-Luciferin (potassium salt) at −20°C in a sealed container, protected from moisture and light (APExBIO).
    • Preparation: Dissolve in sterile water to a final concentration of 15–30 mg/mL for in vivo use; filter-sterilize if necessary.
    • Use: Inject 150 mg/kg body weight for typical mouse imaging; optimize dosage based on animal model and imaging system (Hexa-His).
    • Assay compatibility: Suitable for luciferase reporter, ATP, and contamination assays; not interchangeable with substrates for non-firefly luciferases.
    • Activity window: Bioluminescent signal peaks 10–20 minutes post-injection in mice; monitor kinetics for optimal imaging timing.

    Conclusion & Outlook

    D-Luciferin (potassium salt) from APExBIO (C3654) sets the standard for bioluminescence imaging and luciferase-based assays, combining water solubility, high purity, and robust luminescent output. Its validated performance supports reproducible workflows in oncology, stem cell research, and microbial detection. Strict attention to storage, preparation, and application-specific parameters ensures maximal signal and data fidelity. As molecular imaging advances, D-Luciferin (potassium salt) will remain central to non-invasive, quantitative biological monitoring in preclinical and translational research (Li et al., 2025). For detailed protocols and troubleshooting, consult the product page and referenced internal resources.